Medicare proposes to only cover Alzheimer’s drug aduhelm for use in clinical trials
Clinical guideline on external beam radiation therapy for primary liver cancers released
12 January 2022New research sheds light on COVID-19 vaccine inequities in California
12 January 2022Medicare proposes to only cover Alzheimer’s drug aduhelm for use in clinical trials
(HealthDay)—It’s a move that could severely limit the number of people taking the controversial new Alzheimer’s drug Aduhelm: Medicare on Tuesday proposed to only cover the cost of the pricey medication for people enrolled in approved clinical trials.
